Weiss Multi-Strategy Advisers’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-34,329
Closed -$204K 755
2022
Q3
$204K Hold
34,329
0.01% 610
2022
Q2
$266K Hold
34,329
0.01% 595
2022
Q1
$736K Sell
34,329
-68,421
-67% -$7.61M 0.02% 534
2021
Q4
$11.2M Buy
102,750
+21,646
+27% +$4.84M 0.25% 115
2021
Q3
$14.1M Buy
81,104
+472
+0.6% +$162K 0.3% 109
2021
Q2
$27.9M Buy
80,632
+1,912
+2% +$821K 0.61% 26
2021
Q1
$29.1M Sell
78,720
-825
-1% -$429K 0.64% 23
2020
Q4
$23.1M Buy
+79,545
New +$27.7M 0.45% 59

Other funds holding WGS

Weiss Multi-Strategy Advisers's WGS Position: Q4 2022 in Review

Weiss Multi-Strategy Advisers sold out of GeneDx Holdings (WGS) in Q4 2022, closing a stake of 34,329 shares — an estimated $204K sold.

Weiss Multi-Strategy Advisers first reported a position in WGS in Q4 2020 and held it in 8 quarters. The position peaked at $29.1M in Q1 2021. 86 funds tracked by Wall St. Rank hold WGS as of Q4 2022.

  • Weiss Multi-Strategy Advisers reported no remaining GeneDx Holdings position as of Q4 2022 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 34,329 GeneDx Holdings shares in Q4 2022, an estimated $204K.
  • Weiss Multi-Strategy Advisers first reported a position in GeneDx Holdings in Q4 2020 and held it in 8 quarters.
  • Weiss Multi-Strategy Advisers's GeneDx Holdings position peaked at $29.1M in Q1 2021.
  • 86 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.